Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the ...

EDT Enliven (ELVN) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving ...

Enliven Therapeutics, Inc. ( ($ELVN) ) has released its Q2 earnings. Here is a breakdown of the information Enliven Therapeutics, Inc. presented ...

Enliven Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not only longer, but better.

Get the annual and quarterly balance sheet of Enliven Therapeutics, Inc. (ELVN) including details of assets, liabilities and shareholders' equity.

Enliven Therapeutics Inc shares are currently trading up about 1.6% on the day. The chart below shows the one year performance of ELVN shares, versus its 200 day moving average: ...